Referenser Atopisk dermatit

  1. Wollenberg A, Christen-Zäch S, Taieb A, Paul C, Thyssen J et al. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol 2020;34:2717-2744.
  2. Lind J, Bradley M. Clinical Effectiveness of moisturizers in atopic dermatitis and related disorders. A systematic review. Am J Clin Dermatol 2015;16:341-59.
  3. van Zuuren EJ, Fedorowicz Z, Christensen, R, Lavrijsen APM, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews 2017, Issue 2. CD012119
  4. Skjerven H, Rehbinder E, Vettukattil R, LeBlanc M, Granum B et al. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial. Lancet 2020;395:951-961.
  5. Chalmers JR, Haines RH, Bradshaw LE. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. Lancet 2020;395:962-972
  6. Williams H. Established corticosteroid creams should be applied only once daily in patients with atopic eczema.BMJ 2007;334:1272-1273.
  7. Proudfoot L.,Powell A., Avis S, Barbarot S, Svensson A et.al.The European treatment of severe atopic eczema in children taskforce (TREAT) survey. Br J Dermatol 2013;169:901-909.
  8. Simon D, Bieber T. Systemic therapy for atopic dermatitis. Allergy 2014;69:46-55. Dermatology. 2017;233:344-357.
  9. Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S et al. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. J Am Acad Dermatol 2017; 77:623-633.
  10. Snast I, Reiter O, Hodak E, Friedland R, Mimouni D et al. Are biologics efficacious in atopic dermatitis? A systematic review and meta-analy-sis. Am J Clin Dermatol 2018;19:14-165.
  11. Siegels D, Heratizadeh A, Abraham S, Binnmyr J, Brockow K et al. Systematic treatments in the management of atopic dermatitis: A systematic review and meta-analysis. Allergy 2021;76: 1053-1076.
  12. Regionala riktlinjer systembehandling svår atopisk dermatit https://vardgivare.skane.se/siteassets/1.-vardriktlinjer/lakemedel/riktlinjer/ lakemedelsriktlinjer/systemisk-behandling-av-atopisk-dermatit_reviderad-riktlinje-2019-11-05.pdf
  13. Svedman C, Svensson Å. Atopisk dermatit – utredning och behandling Allergi i Prakxsis 2016;1:6-13.
  14. Schmitt J, von Kobyletzki L, Svensson Å. Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin-inhibitors for atopic eczema: systematic review and meta-analysis of randomised controlled trials. Br J Dermatol 2011;164:415-428
  15. Gisondi P, Girolomoni G. Undertreatment in adult patients with moderate-to-severe atopic dermatitis and other chronic inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2020;34(10):2168-9.
  16. Francis NA, Ridd MJ, Thomas-Jones E, Shepherd V, Butler CC, Hood K, et al.A randomized placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the children with eczema, Antibiotic Management (CREAM) study. Health Technol Assess 2016;20:1-84.
  17. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema:an updated Cochrane review. Br J Dermatol. 2010;163:12-26.
  18. Thomas K, Bradshaw L, Sach T, Cowdell F, Batchelor J et al. Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial. Health Technol Assess 2017;21:1-260.
  19. Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 2018;32:850-878.
  20. Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M et al. European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. J Eur Acad Dermatol Venereol 2019;33:1644-1659.
  21. Yew YW, Thyssen JP, Silverberg JI. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol. 2019;80(2):390-401.
  22. Maintz L, Welchowski T, Herrmann N, Brauer J, Kläschen AS, Fimmers R, et al. Machine Learning-Based Deep Phenotyping of Atopic Dermatitis: Severity-Associated Factors in Adolescent and Adult Patients. JAMA Dermatol. 2021;157(12):1414-24.
  23. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-51
  24. Maintz L, Schmitz MT, Herrmann N, Müller S, Havenith R, Brauer J, et al. Atopic dermatitis: Correlation of distinct risk factors with age of onset in adulthood compared to childhood. Allergy. 2023;78(8):2181-201.
  25. Loman L, Brands MJ, Massella Patsea AAL, Politiek K, Arents BWM, Schuttelaar MLA. Lifestyle factors and hand eczema: A systematic review and meta-analysis of observational studies. Contact Dermatitis. 2022;87:211-32.
  26. Loman L, Politiek K, Schuttelaar MLA. Smoking and obesity are associated with chronic hand eczema and severity of hand eczema: Data from the Dutch general population. Contact Dermatitis. 2022;87:103-6.
  27. Thyssen JP, Schuttelaar MLA, Alfonso JH, Andersen KE, Angelova-Fischer I, Arents BWM, et al. Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis. 2022;86:357-78.
  28. Voorberg AN, Romeijn GLE, de Bruin-Weller MS, Schuttelaar MLA. The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry. Contact Dermatitis. 2022;87:185-91.
  29. Lindberg. M. Meding B. Stenberg B. Svensson Å. Handeksem är en folksjukdom som påverkar livskvalitet och arbetsförmåga. Läkartidningen 2013;110:23-29.
  30. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345-360.
  31. Appiah MM, Haft MA, Eichenfield LF. Atopic Dermatitis: Evolution and Revolution in Therapy. Cutis. 2021;108:113-5.
  32. Bieber T, Paller AS, Kabashima K, Feely M, Rueda MJ, Ross Terres JA, et al. Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options. J Eur Acad Dermatol Venereol. 2022;36:1432-49.
  33. Ali F, Vyas J, Finlay AY. Counting the Burden: Atopic Dermatitis and Health-related Quality of Life. Acta Derm Venereol. 2020;100:adv00161.
  34. Bylund S, Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and Incidence of Atopic Dermatitis: A Systematic Review. Acta Derm Venereol. 2020;100:adv00160.
  35. Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017. Br J Dermatol. 2021;184:304-9.
  36. Thyssen JP, Vestergaard C, Deleuran M, de Bruin-Weller MS, Bieber T, Taieb A, et al. European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitis. J Eur Acad Dermatol Venereol. 2020;34:e839-e42.
  37. Arruda LK, Koplin JJ. Atopic Dermatitis: Aiming for Total Disease Control. J Allergy Clin Immunol Pract. 2021;9:1508-9.
  38. Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022;21:21-40.
  39. Silverwood RJ, Forbes HJ, Abuabara K, Ascott A, Schmidt M, Schmidt SAJ, et al. Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. Bmj. 2018;361:k1786.
  40. Silverwood RJ, Mansfield KE, Mulick A, Wong AYS, Schmidt SAJ, Roberts A, et al. Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016. J Allergy Clin Immunol. 2021;147:1753-1763
  41. 41. Bieber T. In search of the Holy Grail in atopic dermatitis: Will dupilumab become the first disease-modifying atopic dermatitis drug? J Allergy Clin Immunol. 2023;151(3):694-6.
  42. Chen TL, Huang WT, Loh CH, Huang HK, Chi CC. Risk of Venous Thromboembolism Among Adults With Atopic Dermatitis. JAMA Dermatol. 2023;159(7):720-7.
  • Senast uppdaterad: 2023-09-08

Fick du hjälp av informationen på sidan?

Tänk på att

Informationen på webbplatsen är till för offentlig och privat vårdpersonal i Skåne.

Tack för din hjälp att förbättra webbplatsen, dina synpunkter har skickats till webbredaktionen.